Dose dense showed a trend for improved disease-free survival (DFS) and overall survival (OS).
← all excerpts
Randomised trial: survival benefit and safety of adjuvant dose-dense chemotherapy for node-positive breast cancer.
1
—
—
Dose dense showed a trend for improved disease-free survival (DFS) and overall survival (OS).